Esophageal carcinosarcoma: A unique entity with better prognosis

Annals of Surgical Oncology

Volumn 20, Issue 3, 2013, Pages 997-1004

  Wang, Liang ^a   Lin, Yongbin ^a   Long, Hao ^a   Liu, Hui ^a   Rao, Huilan ^a   He, Youjian ^a   Rong, Tiehua ^a   Liang, Ying ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; CISPLATIN; DOCETAXEL;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CARCINOSARCOMA; ESOPHAGEAL CARCINOSARCOMA; ESOPHAGUS CARCINOMA; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; OUTCOME ASSESSMENT; OVERALL SURVIVAL; RECURRENCE FREE SURVIVAL; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; CARCINOSARCOMA; ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHOCYTES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEUTROPHILS; PROGNOSIS; SURVIVAL RATE;

EID: 84875223734     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2658-y     Document Type: Article

References (28)

1. AK Madan AE Long CB Weldon BM Jaffe 2001 Esophageal carcinosarcoma J Gastrointest Surg. 5 414 417 11985984 10.1016/S1091-255X(01)80071-8 1:STN:280:DC%2BD383ksF2nsA%3D%3D
2. LT Xu CF Sun LH Wu, et al. 1984 Clinical and pathological characteristics of carcinosarcoma of the esophagus: report of four cases Ann Thorac Surg. 37 197 203 6703803 10.1016/S0003-4975(10)60324-4 1:STN:280:DyaL2c7lt12qsg%3D%3D
3. S Iyomasa H Kato Y Tachimori, et al. 1990 Carcinosarcoma of the esophagus: a twenty-case study Jpn J Clin Oncol. 20 99 106 2319703 1:STN:280:DyaK3c3gsVyisg%3D%3D
4. DG DeNardo M Johansson LM Coussens 2008 Immune cells as mediators of solid tumor metastasis Cancer Metastasis Rev. 27 11 18 18066650 10.1007/s10555-007-9100-0 1:CAS:528:DC%2BD1cXhtV2gurc%3D
5. F Balkwill A Mantovani 2001 Inflammation and cancer: back to Virchow? Lancet. 357 539 545 11229684 10.1016/S0140-6736(00)04046-0 1:CAS:528: DC%2BD3MXhsVKltb0%3D
6. CS Roxburgh DC McMillan 2010 Role of systemic inflammatory response in predicting survival in patients with primary operable cancer Future Oncol. 6 149 163 20021215 10.2217/fon.09.136 1:CAS:528:DC%2BD1MXhsFyitL3P
7. KJ Halazun A Aldoori HZ Malik, et al. 2008 Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases Eur J Surg Oncol. 34 55 60 17448623 10.1016/j.ejso.2007.02.014 1:STN:280:DC%2BD2sjlvFKksw%3D%3D
8. TW Rice EH Blackstone VW Rusch 2010 7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction Ann Surg Oncol. 17 7 1721 1724 20369299 10.1245/s10434-010-1024-1
9. SR Walsh EJ Cook F Goulder, et al. 2005 Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer J Surg Oncol. 91 181 184 16118772 10.1002/jso.20329 1:STN:280:DC%2BD2MvlvFCjtA%3D%3D
10. Y Kishi S Kopetz YS Chun, et al. 2009 Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy Ann Surg Oncol. 16 614 622 19130139 10.1245/s10434-008-0267-6
11. K Taniyama N Sasaki T Mukai, et al. 1995 Carcinosarcomas of the esophagus Pathol Int. 45 297 302 7551000 10.1111/j.1440-1827.1995.tb03460.x 1:STN:280:DyaK28%2FksVaksA%3D%3D
12. F Enrile PO DeJesus AA Bakst R Baluyot 1973 Pseudosarcoma of the esophagus Cancer 21 1197 1202 10.1002/1097-0142(197305)31:5<1197::AID- CNCR2820310523>3.0.CO;2-9
13. J Parsonnet GD Friedman DP Vandersteen, et al. 1991 Helicobacter pylori infection and the risk of gastric carcinoma N Engl J Med. 325 16 1127 1131 1891020 10.1056/NEJM199110173251603 1:STN:280:DyaK3Mzmslahuw%3D%3D
14. Rokkas T, Pistiolas D, Sechopoulos P, et al. Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis. Clin Gastroenterol Hepatol. 2007;5(12):1413-7, 1417.e1-2.
15. F Islami F Kamangar 2008 Helicobacter pylori and esophageal cancer risk: a meta-analysis Cancer Prev Res (Phila). 1 5 329 338 10.1158/1940-6207.CAPR-08- 0109 1:CAS:528:DC%2BC3cXptFOitrk%3D
16. MJ Blaser 1999 The changing relationships of Helicobacter pylori and humans: implications for health and disease J Infect Dis 179 1523 1530 10228075 10.1086/314785 1:STN:280:DyaK1M3ks1emtw%3D%3D
17. MJ Blaser J Atherton 2004 Helicobacter pylori persistence: biology and disease J Clin Invest 113 321 333 14755326 1:CAS:528:DC%2BD2cXhtFSlsr0%3D
18. KJ Wang RT Wang 2003 Meta-analysis on the epidemiology of Helicobacter pylori infection in China Zhonghua Liu Xing Bing Xue Za Zhi. 24 443 446 12848905
19. T Matysiak-Budnik F Mégraud 2006 Helicobacter pylori infection and gastric cancer Eur J Cancer. 42 6 708 716 16556496 10.1016/j.ejca.2006.01.020 1:CAS:528:DC%2BD28Xjs1GrtrY%3D
20. RZ Sharaiha KJ Halazun F Mirza, et al. 2011 Elevated preoperative neutrophil: lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer Ann Surg Oncol. 18 3362 3369 21547702 10.1245/s10434-011- 1754-8
21. Y Wada O Nakashima R Kutami, et al. 1998 Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration Hepatology. 27 407 414 9462638 10.1002/hep.510270214 1:STN:280:DyaK1c7it1Cksg%3D%3D
22. J Galon A Costes F Sanchez-Cabo, et al. 2006 Type, density, and location of immune cells within human colorectal tumors predict clinical outcome Science. 313 1960 1964 17008531 10.1126/science.1129139 1:CAS:528:DC%2BD28XhtVSnsrnK
23. YH Kusumanto WA Dam GA Hospers, et al. 2003 Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor Angiogenesis. 6 283 287 15166496 10.1023/B:AGEN.0000029415.62384.ba 1:CAS:528:DC%2BD2cXktlykt7g%3D
24. C Fondevila JP Metges J Fuster, et al. 2004 p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer Br J Cancer. 90 206 215 14710231 10.1038/sj.bjc.6601455 1:CAS:528:DC%2BD2cXhtFKgtQ%3D%3D
25. T Tanaka H Ishiguro Y Kuwabara, et al. 2010 Vascular endothelial growth factor C (VEGF-C) in esophageal cancer correlates with lymph node metastasis and poor patient prognosis J Exp Clin Cancer Res. 29 83 20584281 10.1186/1756-9966-29-83
26. P van Hagen MC Hulshof JJ van Lanschot, et al. 2012 Preoperative chemoradiotherapy for esophageal or junctional cancer N Engl J Med. 366 22 2074 2084 22646630 10.1056/NEJMoa1112088
27. CJ Kuo TN Lin CJ Lin, et al. 2010 Clinical manifestation of esophageal carcinosarcoma: a Taiwan experience Dis Esophagus. 23 122 127 19473206 10.1111/j.1442-2050.2009.00976.x
28. DK Zhang XD Su H Long, et al. 2008 Surgical treatment and prognosis in patients with squamous cell carcinoma of thoracic esophagus Zhonghua Wai Ke Za Zhi. 46 17 1333 1336 19094566